» Articles » PMID: 36555658

Telomere Length: A Cardiovascular Biomarker and a Novel Therapeutic Target

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2022 Dec 23
PMID 36555658
Authors
Affiliations
Soon will be listed here.
Abstract

Coronary artery disease (CAD) is a multifactorial disease with a high prevalence, particularly in developing countries. Currently, the investigation of telomeres as a potential tool for the early detection of the atherosclerotic disease seems to be a promising method. Telomeres are repetitive DNA sequences located at the extremities of chromosomes that maintain genetic stability. Telomere length (TL) has been associated with several human disorders and diseases while its attrition rate varies significantly in the population. The rate of TL shortening ranges between 20 and 50 bp and is affected by factors such as the end-replication phenomenon, oxidative stress, and other DNA-damaging agents. In this review, we delve not only into the pathophysiology of TL shortening but also into its association with cardiovascular disease and the progression of atherosclerosis. We also provide current and future treatment options based on TL and telomerase function, trying to highlight the importance of these cutting-edge developments and their clinical relevance.

Citing Articles

Oral intake of degalactosylated whey protein increases peripheral blood telomere length in young and aged mice.

Inui T, Kawamura N, Yamamura M, Kubo K, Yamakage H, Satoh-Asahara N Sci Rep. 2024; 14(1):30859.

PMID: 39730524 PMC: 11681036. DOI: 10.1038/s41598-024-81597-3.


Connecting the Dots: Telomere Shortening and Rheumatic Diseases.

Han F, Riaz F, Pu J, Gao R, Yang L, Wang Y Biomolecules. 2024; 14(10).

PMID: 39456194 PMC: 11506250. DOI: 10.3390/biom14101261.


Genetic liability to human serum metabolites is causally linked to telomere length: insights from genome-wide Mendelian randomization and metabolic pathways analysis.

Liu J, Pan R Front Nutr. 2024; 11:1458442.

PMID: 39253325 PMC: 11381963. DOI: 10.3389/fnut.2024.1458442.


Deciphering the causal association and underlying transcriptional mechanisms between telomere length and abdominal aortic aneurysm.

Zhang J, Xia X, He S Front Immunol. 2024; 15:1438838.

PMID: 39234237 PMC: 11371612. DOI: 10.3389/fimmu.2024.1438838.


Telomeres and SIRT1 as Biomarkers of Gamete Oxidative Stress, Fertility, and Potential IVF Outcome.

Panczyszyn A, Boniewska-Bernacka E, Wertel I, Sadakierska-Chudy A, Goc A Int J Mol Sci. 2024; 25(16).

PMID: 39201341 PMC: 11354255. DOI: 10.3390/ijms25168652.


References
1.
Boniewska-Bernacka E, Panczyszyn A, Klinger M . Telomeres and telomerase in risk assessment of cardiovascular diseases. Exp Cell Res. 2020; 397(2):112361. DOI: 10.1016/j.yexcr.2020.112361. View

2.
Willeit P, Willeit J, Brandstatter A, Ehrlenbach S, Mayr A, Gasperi A . Cellular aging reflected by leukocyte telomere length predicts advanced atherosclerosis and cardiovascular disease risk. Arterioscler Thromb Vasc Biol. 2010; 30(8):1649-56. DOI: 10.1161/ATVBAHA.110.205492. View

3.
de Jesus B, Vera E, Schneeberger K, Tejera A, Ayuso E, Bosch F . Telomerase gene therapy in adult and old mice delays aging and increases longevity without increasing cancer. EMBO Mol Med. 2012; 4(8):691-704. PMC: 3494070. DOI: 10.1002/emmm.201200245. View

4.
Childs B, Baker D, Wijshake T, Conover C, Campisi J, van Deursen J . Senescent intimal foam cells are deleterious at all stages of atherosclerosis. Science. 2016; 354(6311):472-477. PMC: 5112585. DOI: 10.1126/science.aaf6659. View

5.
Mons U, Muezzinler A, Schottker B, Dieffenbach A, Butterbach K, Schick M . Leukocyte Telomere Length and All-Cause, Cardiovascular Disease, and Cancer Mortality: Results From Individual-Participant-Data Meta-Analysis of 2 Large Prospective Cohort Studies. Am J Epidemiol. 2017; 185(12):1317-1326. PMC: 5860628. DOI: 10.1093/aje/kww210. View